安進 AMGN 深 滬
等待開盤 08-21 09:30:00 美东时间
433.73
-8.630
-1.95%
華盛通- 最 高441.34
- 今 開435.78
- 成交量 289.44万股
- 最 低 431.07
- 昨 收 442.36
- 總市值 2344.88亿
- 52周最高 443.20
- 市盈率 靜 30.49
- 換手率 0.54%
- 52周最低 262.35
- 委 比 -26.27%
- 總股本 5.41亿
- 歷史最高 443.20
- 量 比 1.13
- 振 幅 2.32%
- 歷史最低 -30.959
- 每 手 1
- 風險率 36.29%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Fresenius cuts stake in dialysis unit further with 7.8M share sale
German health care provider Fresenius (FMS) on Thursday announced plans to further reduce its stake in its dialysis subsidiary Fresenius Medical Care by agreeing to sell approximately 7.8M shares to a...
今天 01:17
美股大行评级 | 潜在涨幅167.3%！HC Wainwright上调Tango Therapeutics目标价至68美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Tango Therapeutics"买入"评级，目标价从66美元升至68美元；康托·菲茨杰拉德：维持Duos Technologies Group"超配"评级，目标价从26美元升至27美元
08-19 08:37
Snowflake To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwright & Co raised the price target for argenx SE – ADR (NASDAQ:ARGX) from $940 to $1,202. HC Wainwrigh...
08-18 20:26
美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
Amgen, Constellation, Fastly, Keel & Blackstone Shock Wall St.
Insiders have been trading these 5 stocks: (($AMGN)), (($CEG)), (($FSLY)), (($K...
08-15 21:01
9 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often look for circumstances when the market estimation of an option diverges away fro...
08-15 01:35
Barclays Maintains Equal-Weight on Amgen, Raises Price Target to $380
Barclays analyst Emily Field maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $360 to $380.
08-14 22:17
拒绝默沙东、牵手百济！全球最\"红\"Biotech，究竟想干啥？
情理之中，意料之外。 8月10日晚间，一则License-in消息引爆医药圈——百济神州宣布与Revolution Medicines达成临床联合开发与区域商业...
08-14 13:38
Pharma companies sour on Swiss drug applications amid Trump’s MFN policy
Drugmakers are not inclined to seek insurance coverage and, in some cases, even regulatory approvals for their new drugs in Switzerland due to President Donald Trump’s most-favored-nation drug pricing...
08-13 23:58
